Theranostics
Theranostics - a fusion (portmanteau) of "therapeutics" and "diagnostics" - revolutionizes healthcare by integrating molecular diagnostics with targeted therapies. This approach personalizes treatment by tailoring interventions to an individual’s specific disease subtype and genetic profile, ensuring more precise and effective care.
Molecular Imaging
Molecular imaging illuminates the intricate processes of disease at the molecular and cellular levels, enabling early diagnosis and providing real-time, non-invasive monitoring of therapeutic responses.
State-of-the-Art Imaging Facilities:
PET/MRI, PET/CT, SPECT/CT
IVIS, NIR II Fluorescence Imaging
X-ray, Radio-HPLC & TLC
Ultrasound/Photoacoustic Imaging
We offer a seamlessly integrated, all-in-one platform for cutting-edge molecular imaging research and applications.
Chemistry
Our Chemistry Division specializes in the design and synthesis of novel compounds, including:
Small molecules
Peptides
Proteins
Antibodies
These innovations are instrumental in advancing the development of cutting-edge diagnostics and therapeutics for a range of diseases.
Biology
Our biological research spans cellular and animal models to:
Validate disease diagnostics and treatment strategies
Unravel molecular mechanisms driving disease progression and therapy response.
Development of Novel Nanoplatforms
The development of novel nanoplatforms is advancing the frontiers of medical imaging and therapy, enhancing the precision of diagnostics and expanding therapeutic options for complex diseases.
Radiotheranostics
Imaging & Targeted Radioligand Therapy
Radiotheranostics utilizes radionuclides for both diagnosis and treatment, transforming patient care through a precision medicine approach.
Imaging component “sees” the lesions
Therapy agent “treats” the same lesions
Radiotheranostics revolutionizes patient care by using small amounts of radioactive materials to diagnose and treat a variety of diseases, providing vital information that is often unattainable through other imaging technique, and targeted radioligand therapy for precision medicine.